MARA Holdings
MARA
MicroStrategy
MSTR
Coinbase
COIN
NVIDIA
NVDA
Tesla
TSLA
US Stock MarketDetailed Quotes
TECX Tectonic Therapeutic
- 40.900
- -1.120-2.67%
Close Jan 17 16:00 ET
- 40.900
- 0.0000.00%
Pre 04:30 ET
603.38MMarket Cap-13.86P/E (TTM)
44.000High40.885Low199.64KVolume43.000Open42.020Pre Close8.46MTurnover3.54%Turnover RatioLossP/E (Static)14.75MShares53.41052wk High4.01P/B230.96MFloat Cap12.12052wk Low--Dividend TTM5.65MShs Float644.400Historical High--Div YieldTTM7.41%Amplitude6.720Historical Low42.390Avg Price1Lot Size
Tectonic Therapeutic News
Analysts Offer Insights on Healthcare Companies: Tectonic Therapeutic (TECX), Henry Schein (HSIC) and Geron (GERN)
Tectonic Therapeutic Price Target Announced at $65.00/Share by Raymond James
Raymond James Initiates Tectonic Therapeutic(TECX.US) With Buy Rating, Announces Target Price $65
Tectonic Therapeutic Initiated With an Outperform at Raymond James
Wells Fargo Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Maintains Target Price $79
Wells Fargo Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Raises Target Price to $79
Tectonic Therapeutic Is Maintained at Outperform by Leerink Partners
Tectonic Therapeutic Analyst Ratings
Leerink Partners Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Raises Target Price to $69
Leerink Partners Raises Tectonic Therapeutic's Price Target to $69 From $49, Outperform Rating Maintained
Tectonic Therapeutic: Promising Phase 1a Results and Strong Financial Health Justify Buy Rating
TD Cowen Maintains Tectonic Therapeutic(TECX.US) With Buy Rating
TD Cowen Maintains Tectonic Therapeutic(TECX.US) With Buy Rating
TD Cowen Sticks to Their Buy Rating for Tectonic Therapeutic (TECX)
TD Cowen Maintains Tectonic Therapeutic(TECX.US) With Buy Rating
Piper Sandler Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Maintains Target Price $76
TD Cowen Maintains Tectonic Therapeutic(TECX.US) With Buy Rating
Piper Sandler Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Maintains Target Price $76
Piper Sandler Sticks to Their Buy Rating for Tectonic Therapeutic (TECX)
Wells Fargo Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Maintains Target Price $55
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.